K
53
2
MAS
51
4
SCHW
64
2
MRK
22
3
PX
75
5
AZO
46
-3
TRV
53
-3
RSG
68
3
PSA
51
-4
HUM
48
6
FLS
73
-2
DTE
50
3
PCG
93
2
WMT
74
2
WAT
47
5
TEL
60
2
UHS
54
3
NRG
49
-3
ICE
59
-3
AMGN
44
5
K
53
2
MAS
51
4
SCHW
64
2
MRK
22
3
PX
75
5
AZO
46
-3
TRV
53
-3
RSG
68
3
PSA
51
-4
HUM
48
6
FLS
73
-2
DTE
50
3
PCG
93
2
WMT
74
2
WAT
47
5
TEL
60
2
UHS
54
3
NRG
49
-3
ICE
59
-3
AMGN
44
5
Financhill
Back

Pampa Energia SA 10K Form

Buy
74

PAM
Pampa Energia SA

Last Price:
82.37
Seasonality Move:
7.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PAM News And Ratings

See the #1 stock for the next 7 days that we like better than PAM

PAM Financial Statistics

Sales & Book Value

Annual Sales: $1.73B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $58.60
Price / Book: 1.37

Profitability

EPS (TTM): 6.35650
Net Income (TTM): $350.4M
Gross Margin: $625M
Return on Equity: 12.3%
Return on Assets: 6.63%

Pampa Energia SA Earnings Forecast

Key Pampa Energia SA Financial Ratios

  • The Gross Profit Margin over the past 20 years for PAM is 36.09%.
  • The Selling, General & Administrative Expenses for PAM have been equal to 12.99% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 117.88% of Operating Income.
  • The Net Earning history of PAM is 17.44% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 12 years.

Pampa Energia SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Electric Utilities
Sector: Utilities
Current Symbol: PAM
CUSIP: 697660
Website: pampaenergia.com

Debt

Debt-to-Equity Ratio: 0.54
Current Ratio: 2.39
Quick Ratio: 2.11

Price-to-Earnings

Trailing P/E Ratio: 14.55
Forward P/E Ratio: 9.85

PAM Technical Analysis vs Fundamental Analysis

Buy
74
Pampa Energia SA (PAM) is a Buy

Is Pampa Energia SA a Buy or a Sell?

  • Pampa Energia SA stock is rated a Buy
    The current Pampa Energia SA [PAM] share price is $81.89. The Score for PAM is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.